Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens.

Kaleem Z, Swanson PE, Vollmer RT, Humphrey PA.

Am J Clin Pathol. 1998 Jun;109(6):695-703.

PMID:
9620026
2.

Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.

Egan AJ, Lopez-Beltran A, Bostwick DG.

Am J Surg Pathol. 1997 Aug;21(8):931-5.

PMID:
9255256
3.

Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.

Yaskiv O, Cao D, Humphrey PA.

Am J Surg Pathol. 2010 Apr;34(4):556-61. doi: 10.1097/PAS.0b013e3181d2a549.

PMID:
20216381
4.

Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.

Cheville JC, Bostwick DG.

Am J Surg Pathol. 1995 Sep;19(9):1068-76.

PMID:
7544958
5.

Ki-67 expression in early prostate cancer and associated pathological lesions.

Feneley MR, Young MP, Chinyama C, Kirby RS, Parkinson MC.

J Clin Pathol. 1996 Sep;49(9):741-8.

6.
7.

Histology and cellular kinetics of prostatic atrophy.

Ruska KM, Sauvageot J, Epstein JI.

Am J Surg Pathol. 1998 Sep;22(9):1073-7.

PMID:
9737239
8.

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.

Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC.

Cancer. 1995 Jan 15;75(2):522-9.

9.
10.

Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy.

Levi AW, Epstein JI.

Am J Surg Pathol. 2000 Aug;24(8):1039-46.

PMID:
10935644
11.

Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.

Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA Jr, Shappell SB.

Hum Pathol. 2000 Sep;31(9):1146-54.

PMID:
11014584
12.

Adenocarcinoma of the prostate with atrophic features.

Cina SJ, Epstein JI.

Am J Surg Pathol. 1997 Mar;21(3):289-95.

PMID:
9060598
13.
15.

Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.

Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW.

Cancer. 2002 Dec 15;95(12):2487-93.

16.
18.
20.

High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.

Zhao J, Epstein JI.

Am J Surg Pathol. 2009 Apr;33(4):583-90. doi: 10.1097/PAS.0b013e31818a5c6c.

PMID:
19033862

Supplemental Content

Support Center